1. Home
  2. RCI vs BBIO Comparison

RCI vs BBIO Comparison

Compare RCI & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rogers Communication Inc.

RCI

Rogers Communication Inc.

HOLD

Current Price

$34.54

Market Cap

17.1B

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$82.80

Market Cap

15.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCI
BBIO
Founded
1960
2015
Country
Canada
United States
Employees
24000
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1B
15.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RCI
BBIO
Price
$34.54
$82.80
Analyst Decision
Hold
Strong Buy
Analyst Count
3
25
Target Price
$44.00
$86.33
AVG Volume (30 Days)
1.3M
3.0M
Earning Date
04-22-2026
05-12-2026
Dividend Yield
4.01%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$502,076,000.00
Revenue This Year
$6.78
$89.45
Revenue Next Year
$1.45
$73.78
P/E Ratio
$4.12
N/A
Revenue Growth
N/A
126.26
52 Week Low
$31.38
$45.42
52 Week High
$41.14
$93.42

Technical Indicators

Market Signals
Indicator
RCI
BBIO
Relative Strength Index (RSI) 50.58 56.36
Support Level $31.87 $78.98
Resistance Level $38.99 $85.34
Average True Range (ATR) 0.78 2.27
MACD 0.15 -0.65
Stochastic Oscillator 59.63 47.73

Price Performance

Historical Comparison
RCI
BBIO

About RCI Rogers Communication Inc.

Rogers Communications is the largest wireless service provider in Canada with more than 11 million subscribers, equating to one-third of the total Canadian market. Rogers' wireless business accounts for more than half of total revenue and has been growing at a higher rate than other segments. The cable segment, which provides about 38% of total revenue after acquiring Shaw, offers home internet, television, and landline phone service to consumers and businesses. Remaining sales come from Rogers' media unit, which owns and operates various television and radio stations and major Toronto sports franchises, including the Blue Jays, Maple Leafs, Raptors, Toronto FC, and Argonauts.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: